BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 19852933)

  • 1. The TryPIKinome of five human pathogenic trypanosomatids: Trypanosoma brucei, Trypanosoma cruzi, Leishmania major, Leishmania braziliensis and Leishmania infantum--new tools for designing specific inhibitors.
    Bahia D; Oliveira LM; Lima FM; Oliveira P; Silveira JF; Mortara RA; Ruiz JC
    Biochem Biophys Res Commun; 2009 Dec; 390(3):963-70. PubMed ID: 19852933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of antimicrobial peptides with Leishmania and trypanosomes and their functional role in host parasitism.
    McGwire BS; Kulkarni MM
    Exp Parasitol; 2010 Nov; 126(3):397-405. PubMed ID: 20159013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Novel Chemical Scaffolds Inhibiting Trypanothione Synthetase from Pathogenic Trypanosomatids.
    Benítez D; Medeiros A; Fiestas L; Panozzo-Zenere EA; Maiwald F; Prousis KC; Roussaki M; Calogeropoulou T; Detsi A; Jaeger T; Šarlauskas J; Peterlin Mašič L; Kunick C; Labadie GR; Flohé L; Comini MA
    PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004617. PubMed ID: 27070550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxicity of (2,2':6',2''-terpyridine)platinum(II) complexes to Leishmania donovani, Trypanosoma cruzi, and Trypanosoma brucei.
    Lowe G; Droz AS; Vilaivan T; Weaver GW; Tweedale L; Pratt JM; Rock P; Yardley V; Croft SL
    J Med Chem; 1999 Mar; 42(6):999-1006. PubMed ID: 10090783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei.
    Rojas Vargas JA; López AG; Pérez Y; Cos P; Froeyen M
    Parasitol Res; 2019 May; 118(5):1533-1548. PubMed ID: 30903349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taiwaniaquinoid and abietane quinone derivatives with trypanocidal activity against T. cruzi and Leishmania spp.
    Ramírez-Macías I; Marín C; Es-Samti H; Fernández A; Guardia JJ; Zentar H; Agil A; Chahboun R; Alvarez-Manzaneda E; Sánchez-Moreno M
    Parasitol Int; 2012 Sep; 61(3):405-13. PubMed ID: 22366342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and evaluation of inhibitors of trypanosomal and leishmanial dihydrofolate reductase.
    Chowdhury SF; Villamor VB; Guerrero RH; Leal I; Brun R; Croft SL; Goodman JM; Maes L; Ruiz-Perez LM; Pacanowska DG; Gilbert IH
    J Med Chem; 1999 Oct; 42(21):4300-12. PubMed ID: 10543874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional characterization of stage-specific aminotransferases from trypanosomatids.
    Marciano D; Maugeri DA; Cazzulo JJ; Nowicki C
    Mol Biochem Parasitol; 2009 Aug; 166(2):172-82. PubMed ID: 19443056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of the kinomes of three pathogenic trypanosomatids: Leishmania major, Trypanosoma brucei and Trypanosoma cruzi.
    Parsons M; Worthey EA; Ward PN; Mottram JC
    BMC Genomics; 2005 Sep; 6():127. PubMed ID: 16164760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro inhibitory effects of palmatine from Enantia chlorantha on Trypanosoma cruzi and Leishmania infantum.
    Nkwengoua ET; Ngantchou I; Nyasse B; Denier C; Blonski C; Schneider B
    Nat Prod Res; 2009; 23(12):1144-50. PubMed ID: 19662580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simple dialkyl pyrazole-3,5-dicarboxylates show in vitro and in vivo activity against disease-causing trypanosomatids.
    Reviriego F; Olmo F; Navarro P; Marín C; Ramírez-Macías I; García-España E; Albelda MT; Gutiérrez-Sánchez R; Sánchez-Moreno M; Arán VJ
    Parasitology; 2017 Aug; 144(9):1133-1143. PubMed ID: 28367781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine analogues as selective inhibitors of glyceraldehyde-3-phosphate dehydrogenase of Trypanosomatidae via structure-based drug design.
    Bressi JC; Verlinde CL; Aronov AM; Shaw ML; Shin SS; Nguyen LN; Suresh S; Buckner FS; Van Voorhis WC; Kuntz ID; Hol WG; Gelb MH
    J Med Chem; 2001 Jun; 44(13):2080-93. PubMed ID: 11405646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective tight binding inhibitors of trypanosomal glyceraldehyde-3-phosphate dehydrogenase via structure-based drug design.
    Aronov AM; Verlinde CL; Hol WG; Gelb MH
    J Med Chem; 1998 Nov; 41(24):4790-9. PubMed ID: 9822549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Searching the Tritryp genomes for drug targets.
    Myler PJ
    Adv Exp Med Biol; 2008; 625():133-40. PubMed ID: 18365664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and Synthesis of Broad Spectrum Trypanosomatid Selective Inhibitors.
    Fraser AL; Menzies SK; King EFB; Tulloch LB; Gould ER; Zacharova MK; Smith TK; Florence GJ
    ACS Infect Dis; 2018 Apr; 4(4):560-567. PubMed ID: 29313667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signalling the genome: the Ras-like small GTPase family of trypanosomatids.
    Field MC
    Trends Parasitol; 2005 Oct; 21(10):447-50. PubMed ID: 16112905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and biochemical characterization of novel glucokinases from Trypanosoma cruzi and Leishmania spp.
    Cáceres AJ; Quiñones W; Gualdrón M; Cordeiro A; Avilán L; Michels PA; Concepción JL
    Mol Biochem Parasitol; 2007 Dec; 156(2):235-45. PubMed ID: 17904661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-Anti-Parasitic Activity of Arylidene Ketones and Thiazolidene Hydrazines against Trypanosoma cruzi and Leishmania spp.
    Álvarez G; Perdomo C; Coronel C; Aguilera E; Varela J; Aparicio G; Zolessi FR; Cabrera N; Vega C; Rolón M; Rojas de Arias A; Pérez-Montfort R; Cerecetto H; González M
    Molecules; 2017 May; 22(5):. PubMed ID: 28481276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo antitrypanosomatid activity of 5-nitroindazoles.
    Boiani L; Gerpe A; Arán VJ; Torres de Ortiz S; Serna E; Vera de Bilbao N; Sanabria L; Yaluff G; Nakayama H; Rojas de Arias A; Maya JD; Morello JA; Cerecetto H; González M
    Eur J Med Chem; 2009 Mar; 44(3):1034-40. PubMed ID: 18706738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of casein kinase 1 block the growth of Leishmania major promastigotes in vitro.
    Allocco JJ; Donald R; Zhong T; Lee A; Tang YS; Hendrickson RC; Liberator P; Nare B
    Int J Parasitol; 2006 Oct; 36(12):1249-59. PubMed ID: 16890941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.